BUPRENORPHINE ANALOGS
PROBLEM TO BE SOLVED: To provide buprenorphine analogs having activity as opioid receptor agonists and/or antagonists.SOLUTION: This invention relates to compositions represented by formula (I). The compounds of the Invention are useful for treating pain, constipation, and other conditions modulated...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English Japanese |
| Published |
02.06.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | PROBLEM TO BE SOLVED: To provide buprenorphine analogs having activity as opioid receptor agonists and/or antagonists.SOLUTION: This invention relates to compositions represented by formula (I). The compounds of the Invention are useful for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors. This invention further relates to a using method for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors.SELECTED DRAWING: Figure 1
【課題】オピオイド受容体アゴニスト及び／又はアンタゴニストとして活性を有するブプレノルフィン類似体の提供。【解決手段】式（Ｉ）で表される化合物。前記化合物は疼痛、便秘並びにオピオイド及びＯＲＬ−１受容体の活性により調節される他の状態を治療するために使用する方法。【選択図】図１ |
|---|---|
| AbstractList | PROBLEM TO BE SOLVED: To provide buprenorphine analogs having activity as opioid receptor agonists and/or antagonists.SOLUTION: This invention relates to compositions represented by formula (I). The compounds of the Invention are useful for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors. This invention further relates to a using method for treating pain, constipation, and other conditions modulated by activity of opioid and ORL-1 receptors.SELECTED DRAWING: Figure 1
【課題】オピオイド受容体アゴニスト及び／又はアンタゴニストとして活性を有するブプレノルフィン類似体の提供。【解決手段】式（Ｉ）で表される化合物。前記化合物は疼痛、便秘並びにオピオイド及びＯＲＬ−１受容体の活性により調節される他の状態を治療するために使用する方法。【選択図】図１ |
| Author | TAFESSE LAYKEA KYLE DONALD J |
| Author_xml | – fullname: KYLE DONALD J – fullname: TAFESSE LAYKEA |
| BookMark | eNrjYmDJy89L5WQQdQoNCHL18w8K8PD0c1Vw9HP08XcP5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGZoYGRoaGpo7GRCkCAKwHIRo |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | ブプレノルフィン類似体 |
| ExternalDocumentID | JP2016102115A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_JP2016102115A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:36:07 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_JP2016102115A3 |
| Notes | Application Number: JP20150226945 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160602&DB=EPODOC&CC=JP&NR=2016102115A |
| ParticipantIDs | epo_espacenet_JP2016102115A |
| PublicationCentury | 2000 |
| PublicationDate | 20160602 |
| PublicationDateYYYYMMDD | 2016-06-02 |
| PublicationDate_xml | – month: 06 year: 2016 text: 20160602 day: 02 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | PURDUE PHARMA LP |
| RelatedCompanies_xml | – name: PURDUE PHARMA LP |
| Score | 3.155442 |
| Snippet | PROBLEM TO BE SOLVED: To provide buprenorphine analogs having activity as opioid receptor agonists and/or antagonists.SOLUTION: This invention relates to... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | BUPRENORPHINE ANALOGS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160602&DB=EPODOC&locale=&CC=JP&NR=2016102115A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTU0S001szDQNTI3N9AF9jcMdC1Nkox1LSyB9YuBcVKSMfj-FF8_M49QE68I0wgmhmzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dGwKb4wZGai5Otq4B_i7-zmrOzrZeAWp-QWA50C3WhqaOzAysoHY06KB91zAn0LaUAuQ6xU2QgS0AaFxeiRADU1aiMAOnM-zqNWEGDl_ojDeQCc18xSIMok6hwPDy8w8K8PD0c1Vw9HP08XcPFmVQcnMNcfbQBZofD_dNvFcAkluMxRhYgN38VAkGBWDLJMkiLcnMOCXFGNhnMrdINk-xSDY0TTUBnYqVZC7JII3HICm8stIMXCAeeImTkQwDS0lRaaossDItSZIDBwIAY7lyww |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNa0WtjyKSWzDvpIcgeZrGZBNqKr2FbhJBBS024t93sqTaU2_LDgy7A7Mz3-7ONwC3qqhVlWYIvKTrAo94Q-DHCpV5Y4zxRZAplVn_lJhowUwJ5-q8A-_rWhjGE_rDyBHRowr095qd18v_SyyX_a1c3dFXnPq89zPT5Vp0LGI6Lkica5temriJwzmOGaYcmTJZ08VaVK0d2NUbet4md3q2m7KU5WZM8Q9hL0V1H_URdN4Wfeg569ZrfdiP2xdvHLbOtzqGgT1De5FkmgYT4o0sYkXJw9MAbnwvcwIe9ed_u8nDdGMt8gl0EeZXpzDCzIQaL1STy1JGzKQbhV4ahahWSsOKRfUzGG5RdL5Veg29IIujPJqQxyEcNBL23Um6gG799V1dYmCt6RUzyC_pQHWw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BUPRENORPHINE+ANALOGS&rft.inventor=KYLE+DONALD+J&rft.inventor=TAFESSE+LAYKEA&rft.date=2016-06-02&rft.externalDBID=A&rft.externalDocID=JP2016102115A |